1.2.1. Developing effective prevention and screening programmes and improving the assessment of disease susceptibility

The development of prevention and screening programmes depends on the identification of early biomarkers (including functional and behavioural) of risk and of disease onset, and their design should be informed by internationally accepted criteria. Their deployment depends on the testing and validation of screening methods and programmes. Knowledge should be generated and methods developed for identifying individuals and populations at a clinically relevant increased risk of disease. Identifying individuals and populations at high risk of disease will allow personalised, stratified and collective strategies for efficacious and cost-effective disease prevention to be developed.

← 1.2. Preventing disease · All articles · anx_I__cpt_1__cpt_6__cpt_1__cpt_2__cpt_1__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-04 · Text as adopted (Official Journal); later amendments are not incorporated in this text.